Molecular biology of heart disease synopsis of the pathophysiological basis of cardiac hypertrophy, familial hypertrophic cardiomyopathy, long QT syndrome and marfan syndrome

Internal Medicine

Volumn 35, Issue 4, 1996, Pages 243-248

  Kurabayashi, Masahiko ^a   Yazaki, Yoshio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cardiac hypertrophy; Familial hypertrophic cardiomyopathy; Long QT syndrome; Marfan syndrome

Indexed keywords

BIOLOGICAL MODEL; CARDIOMEGALY; GENETICS; HEART DISEASE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MARFAN SYNDROME; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; REVIEW;

CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; HEART DISEASES; HUMANS; LONG QT SYNDROME; MARFAN SYNDROME; MODELS, CARDIOVASCULAR; MOLECULAR BIOLOGY;

EID: 0030120049     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.35.243     Document Type: Article

References (46)

1. Chien KR. Molecular advances in cardiovascular biology. Science 260: 916, 1993
2. Morgan HE, Gordon EE, Kira Y, et al Biochemical mechanisms of cardiac hypertrophy. Annu Rev Physiol 49: 535, 1987.
3. Yazaki Y, Raben MS. Cardiac myosin adenosine etriphosphatase of rat and mouse: Distinctive enzymatic properties compared with rabbit and dog cardiac myosin. Circ Res 35: 15, 1974.
4. Hoh JF, McGrath PA, Hale PT. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol 10: 1053, 1978.
5. Lompre AM, Nadal-Ginard B, Mahdavi V. Expression of the cardiac ventricular α- and β-myosin heavy chain genes is developmentalty and hormonaliy regulated. J Biol Chem 259: 6437, 1984.
6. Kurabayashi M, Tsuchimochi H, Komuro I, Takaku F, Yazaki Y. Molecular cloning and characterization of human cardiac α- and β-form myosin heavy chain complementary DNA clones: Regulation of expression during development and pressure overload in human atrium. J Clin Invest 82: 524, 1988.
7. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339, 1988.
8. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertophy: molecular studies of an adaptive physiologic response. FASEB J 5: 3037, 1991.
9. Kurabayashi M, Komuro I, Tsuchimochi H, Takaku F, Yazaki Y. Molecular cloning and characterization of human atrial and ventricular myosin alkali light chain cDNA clone. J Biol Chem 263: 13930, 1988.
10. Komuro I, Kurabayashi M, Takaku F, Yazaki Y. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res 62: 1075, 1988.
11. Starksen NF, Simpson PC, Bishopric N, et al Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression Proc Natl Acad Sci USA 83: 8348, 1986.
12. Simpson P. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an α 1 adrenergic response. J Clin Invest 72: 732, 1983.
13. Knowlton KU, Baracchini E, Ross RS, et al. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during α-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem 266: 7759, 1991.
14. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 85: 507, 1990.
15. Komuro I, Kaida T, Shibazaki Y, et al. Stretching cardiac myocytes stimulates protooncogene expression. J Biol Chem 265: 3595, 1990.
16. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 55: 55, 1993.
17. Yamazaki T, Tobe K, Hoh E, et al. Mechanical loading activates mitogenactivated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem 268: 12069, 1993.
18. Aceto JF. Baker KM. [Sarl]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 258: H806, 1990.
19. Sasaki K, Yamano Y, Bardhan S, et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-I receptor. Nature 351: 230, 1991.
20. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351: 233, 1991.
21. Kambayashi Y, Bardhan S, Takahashi K, et al. Molecular cloning of a novel angiotensin II type II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 268: 24543, 1993.
22. Mukoyama M, Nakajima M, Horiuchi M, et al. Expression cloning of type-2 angiotensin II receptor reveals a unique class of seven-tramsmembrane receptors. J Biol Chem 268: 24539, 1993.
23. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 92: 1142, 1995.
24. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines. causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92: 4862, 1995.
25. Jarcho JA, McKenna W, Pare JA, Solomon S, Holcombe R, Dickie S, et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 321: 1372, 1989.
26. Geisterfer-Lowrance AAT, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation Cell 62: 999, 1990.
27. Stiaceski AJ, Geisterfer-Lowrance A, Seidman CE, Seidman JG, Leinwand LA. Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 91: 589, 1994.
28. Solomon SD, Jarcho JA, McKenna W, et al. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 86: 993, 1990.
29. Nishi H, Kimura A, Harada H, Toshima H, Sasazuki T Novel missense mutation in cardiac β myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy Biochem Biophys Res Commun 188: 379, 1992
30. Watkis H, MacRae C, Thierfelder L, et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3, Nat Genet 3: 333, 1993.
31. Thierfelder L, MacRae C, Watkins H, et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 90: 6270, 1993.
32. Carrier L, Hengstenberg C, Beckmann JS, et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet 4:311, 1993.
33. Thierfelder L, Watkins H, MacRae C, et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of sarcomere. Cell 77: 701, 1994.
34. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332: 1058, 1995.
35. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 89: 22, 1994 (see comments).
36. Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 93: 280, 1994.
37. Benhorin J, Kalman YM, Medina A, et al. Evidence of genetic heterogeneity in the long QT syndrome. Science 260: 1960, 1993 (letter, comment).
38. Keating M, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrythmia. the long QT syndrome, and the Harvey ras-1 gene. Science 252: 704, 1991 (see comments).
39. Jiang C, Atkinson D, Towbin J, et al. Two long QT syndrome loci map to chromosome 3 and 7 with evidence for further heterogeneity. Nat Genet 8: 141, 1994 (see comments).
40. Keating MT. Genetic approachesto cardiovascular disease' supravalvular aortic stenosis, Williams syndrome, and long QT syndrome. Circulation 92: 142, 1995.
41. 2+ and modulated by CAMP Nature 365: 445, 1993.
42. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrythmia: HERG mutations cause long QT syndrome. Cell 80: 795, 1995
43. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrythmia: HERG encodes the Ikr potassium channel. Cell 81: 299, 1995.
44. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80: 805, 1995.
45. Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352: 337, 1991 (see comments).
46. Tsipouras P, Del Mastro R, Sarfarazi M, et al. Genetic linkage of the Marfan syndrome, ectopia lentis and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The international Marfan Syndrome Collaborative Study. New Engl J Med 326:905, 1992